Market revenue in 2023 | USD 652.4 million |
Market revenue in 2030 | USD 1,050.9 million |
Growth rate | 7% (CAGR from 2023 to 2030) |
Largest segment | Frozen nondonor |
Fastest growing segment | Frozen Nondonor |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro fertilization market will help companies and investors design strategic landscapes.
Frozen nondonor was the largest segment with a revenue share of 48.05% in 2023. Horizon Databook has segmented the Australia in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2018 to 2030.
The fertility services market in Australia is expected to witness substantial growth in the forecast period due to several factors. These include an increase in infertility cases, a trend of delayed pregnancies among women, advancements in fertility procedures, and numerous fertility clinics with skilled medical professionals.
The availability of advanced fertility treatments, a rise in disposable income, and favorable reimbursement policies contribute to the market's expansion in Australia. Recent innovations in ART and improvements in success rates are also projected to drive the demand for fertility services in the future.
However, the higher cost associated with fertility services may pose a challenge to the market's growth. Furthermore, key players focusing on new launches in the country are expected to boost the growth of the market.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia in vitro fertilization market , including forecasts for subscribers. This country databook contains high-level insights into Australia in vitro fertilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account